Short-term efficacy and safety of l-ornithine l-aspartate therapy in patients with cirrhosis and minimal hepatic encephalopathy: a real-life cohort study

Short-term efficacy and safety of l-ornithine l-aspartate therapy in patients with cirrhosis and minimal hepatic encephalopathy: a real-life cohort study

Introduction and Objectives: MHE is related to a higher risk of accidents and deterioration in the quality of life; it can be detected with PHES and CFP. There is currently insufficient evidence that treatment with oral LOLA improves performance in PHES and CFP in patients with MHE. This study aimed...

Full description

Bibliographic Details
Main Authors: AB Moreno-Cobos, F Higuera-de la Tijera, CI Hinojosa-Segura, D Montemira-Orozco, J Reyes-Méndez, IG Cruz-Reyes, J Zavala-Ramírez, D Santana-Vargas, A Servín-Caamaño, JM Abdo-Francis, JL Pérez- Hernandez
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268122001259

Internet

http://www.sciencedirect.com/science/article/pii/S1665268122001259

Similar Items